Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study

BACKGROUND: Approximately one-third of people with schizophrenia have elevated levels of antigliadin antibodies of the immunoglobulin G type (AGA IgG) — a higher rate than seen in healthy controls. We performed the first double-blind clinical trial of gluten-free versus gluten-containing diets in a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Psychiatry Neurosci
Auteurs principaux: Kelly, Deanna L., Demyanovich, Haley K., Rodriguez, Katrina M., Čiháková, Daniela, Talor, Monica V., McMahon, Robert P., Richardson, Charles M., Vyas, Gopal, Adams, Heather A., August, Sharon M., Fasano, Alessio, Cascella, Nicola G., Feldman, Stephanie M., Liu, Fang, Sayer, MacKenzie A., Powell, Megan M., Wehring, Heidi J., Buchanan, Robert W., Gold, James M., Carpenter, William T., Eaton, William W.
Format: Artigo
Langue:Inglês
Publié: Joule Inc. 2019
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6606425/
https://ncbi.nlm.nih.gov/pubmed/30938127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/jpn.180174
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires